[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Tamiflu in 2009 and Remdesivir in 2019 and what will be the next wonder drug?

Tamiflu in 2009 and Remdesivir in 2019 and what will be the next wonder drug?

by Jackie (née Heneghan) Peck | Jul 26, 2021 | Blog

What have we learned in ten years? I was a pharmacist in retail practice in 2009 and was a site that collected all the unused Tamiflu which ended up being destroyed having cost billions across the world.

Digital Consultations, Que busting and Inequality

Digital Consultations, Que busting and Inequality

by Jackie (née Heneghan) Peck | Jul 26, 2021 | Blog, NHS

The number of digital consultations has exploded during the pandemic and for some it has been fantastic, but for other is in not a suitable mode of to name a few; elderly who are not silver surfers and autistic children.

Remote Auditing versus On Site Auditing

Remote Auditing versus On Site Auditing

by Charlotte Abbott | Jul 22, 2021 | Audit, Blog

Remote Auditing versus On Site Auditing: For the last 16 months the pharmaceutical world has had to get used to remote auditing as opposed to auditing in person.

Risk Assessments – Evaluating hazards

Risk Assessments – Evaluating hazards

by Charlotte Abbott | Jul 22, 2021 | Blog, Risk Assessments

Risk Assessments: The aim of writing one is to evaluate hazards, then remove that hazard or minimise the level of its risk by adding control measures, as necessary.

WDA(H) & Import – New Guidelines:

WDA(H) & Import – New Guidelines:

by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)

Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi

API registration

API registration

by Steven Hewison | Jul 21, 2021 | API Registration, Blog

API registration is an MHRA requirement if you manufacture, import or distribute active substances and you are based in the UK.

« Older Entries
Next Entries »

Recent Posts

  • Pharmacy updates – checked and bagged prescriptions
  • 2026 RP FORUM – Book you place today!
  • Weekend Cogent Courses now available – New for 2026

Upcoming Courses

  • GDP/RP Cogent Gold Standard Online Training on 13 January 2026
  • GDP Audit Online Training on 21 January 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 27 January 2026 10:00 am
  • Intro to the Responsible Person (import) Role (Online) on 28 January 2026
  • Active Pharmaceutical Ingredient (API) and Clinical Trials Online Training on 29 January 2026 2:00 pm

MHRA Alerts & Recalls

MHRA Safety Roundup: December 2025
18 December 2025
Class 3 Medicines Recall: Activase Pharmaceuticals Limited, Prednisolone 5mg Soluble Tablets, EL(25)A/54
15 December 2025
Field Safety Notices: 8 - 12 December 2025
15 December 2025
Class 2 Medicines Recall: Hameln Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion, EL(25)A/53
11 December 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow